(Total Views: 357)
Posted On: 12/23/2019 8:42:50 PM
Post# of 153903
Nice, I like these two statements
BTD Pure Plays
The reason the list of pure plays is so small is because a little less than half got swallowed up by big pharma. All the companies with 2 or more BTD were gobbled up by big pharma. . This list essentially represents low hanging fruit for a Big Pharma acquisition. Any company with 2 or more BTD’s would be in the hot zone for acquisition. Dissecting this list, the companies with the lowest market capitalization were targeting disease indications that represent small patient populations.
Quote:
Leronlimab is a platform technology drug and they could see a minimum of 2 to 4 BTD’s in the coming year.
BTD Pure Plays
The reason the list of pure plays is so small is because a little less than half got swallowed up by big pharma. All the companies with 2 or more BTD were gobbled up by big pharma. . This list essentially represents low hanging fruit for a Big Pharma acquisition. Any company with 2 or more BTD’s would be in the hot zone for acquisition. Dissecting this list, the companies with the lowest market capitalization were targeting disease indications that represent small patient populations.
(2)
(0)
